Form 4: Solstice Advanced Materials SVP Boosts Equity Holdings

Sentiment:

Statement of Changes in Beneficial Ownership


Simon Mawson, SVP of Solstice Advanced Materials Inc., reported an increase in his beneficial ownership of company equity through new Restricted Stock Unit grants.

Summary

  • Simon Mawson, SVP, Elec & Spec Materials at Solstice Advanced Materials Inc. (SOLS), filed a Form 4 detailing changes in his beneficial ownership.
  • Mawson acquired a total of 47 Restricted Stock Units (RSUs) on June 10, 2026, as dividend equivalent rights.
  • These newly acquired RSUs are subject to various vesting schedules, with dates ranging from August 1, 2026, to February 24, 2029, contingent on continued employment.
  • Following these transactions, Mawson directly owns 1,257 shares of common stock.
  • His total beneficial ownership of derivative securities now includes 43,258 Restricted Stock Units and 24,343 Stock Options.
  • The stock options have exercise prices ranging from $43.65 to $50.59 and expiration dates between June 12, 2032, and March 2, 2035.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, as it indicates an executive's continued accumulation of company equity, aligning their interests with shareholders, though it's a routine compensation event rather than an open market purchase.

Positives

  • An executive acquiring additional equity, even through grants, generally signals continued alignment of management's interests with those of shareholders.
  • The grants of dividend equivalent rights in RSUs demonstrate the company's commitment to long-term incentive compensation for its senior leadership.

Negatives

  • The filing does not indicate any open market purchases of common stock by the SVP, which would typically be a stronger signal of confidence.

Risks

  • The value of the RSUs and stock options is tied to the future performance of Solstice Advanced Materials Inc.'s stock price, exposing the holder to market risk.
  • Vesting of RSUs and exercisability of options are contingent on continued employment, posing a risk to the executive if employment ceases before vesting.

Future Outlook

The future outlook for Simon Mawson's equity holdings is tied to the company's performance and his continued employment, with various tranches of RSUs and stock options scheduled to vest and become exercisable over the next several years, extending through March 2029 for vesting and March 2035 for option expiration.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders, providing transparency into executive compensation and ownership changes. The acquisition of RSUs as dividend equivalents is a common practice in executive compensation packages, aligning executive interests with long-term shareholder value creation, similar to practices seen across the advanced materials sector.

Comparison to Industry Standards

  • Executive compensation structures, including grants of Restricted Stock Units and stock options, are standard practice across publicly traded companies, particularly in specialized industries like advanced materials.
  • The vesting schedules, extending over multiple years, are typical for long-term incentive plans designed to retain key talent and encourage sustained performance, comparable to those observed at peers such as DuPont (DD) or LyondellBasell (LYB).

Related Party Transactions

  • The acquisition of Restricted Stock Units as dividend equivalent rights represents a form of compensation from the issuer to a key executive, which is a standard related-party transaction within the scope of executive incentive plans.

Stakeholder Impact

  • Shareholders: The increase in executive equity ownership, even through grants, can be seen as a positive signal of management's commitment and alignment with shareholder interests.
  • Employees: The structure of long-term incentives for senior management can influence overall compensation philosophy and morale within the company.

Next Steps

  • Various tranches of Restricted Stock Units are scheduled to vest on specific dates between August 1, 2026, and October 30, 2029, subject to continued employment.
  • Stock options will continue to vest and become exercisable on various dates between June 13, 2026, and March 3, 2029.

Key Dates

DateDescription
2026-02-23First installment vesting date for 4,833 stock options.
2026-03-01First installment vesting date for 7,691 stock options.
2026-03-03First installment vesting date for 9,312 stock options.
2026-06-10Transaction date for the acquisition of 47 Restricted Stock Units (dividend equivalent rights).
2026-06-12Signature date of the Form 4 filing.
2026-06-13Vesting date for 2,507 stock options.
2026-08-01First installment vesting date for 5 Restricted Stock Units.
2027-02-23Second installment vesting date for 4,833 stock options.
2027-02-24First installment vesting date for 6 Restricted Stock Units.
2027-03-01Vesting date for 2 Restricted Stock Units and second installment vesting date for 7,691 stock options.
2027-03-03First installment vesting date for 6 Restricted Stock Units and second installment vesting date for 9,312 stock options.
2027-03-17First installment vesting date for 7 Restricted Stock Units.
2027-08-01Second installment vesting date for 5 Restricted Stock Units.
2028-02-24Second installment vesting date for 6 Restricted Stock Units.
2028-03-01Third installment vesting date for 7,691 stock options.
2028-03-03Vesting date for 2 Restricted Stock Units and second installment vesting date for 6 Restricted Stock Units and third installment vesting date for 9,312 stock options.
2028-03-17Second installment vesting date for 7 Restricted Stock Units.
2028-10-30First installment vesting date for 19 Restricted Stock Units.
2029-02-24Third installment vesting date for 6 Restricted Stock Units.
2029-03-03Third installment vesting date for 6 Restricted Stock Units and fourth installment vesting date for 9,312 stock options.
2029-10-30Second installment vesting date for 19 Restricted Stock Units.
2032-06-12Expiration date for 2,507 stock options.
2033-02-22Expiration date for 4,833 stock options.
2034-02-28Expiration date for 7,691 stock options.
2035-03-02Expiration date for 9,312 stock options.

Recommendation

hold

This Form 4 filing details routine executive compensation in the form of RSU grants and existing option holdings. While it shows continued alignment of management interests, it does not present new information significant enough to warrant a change in investment recommendation. It's a standard disclosure of an expected event.

Keywords

Solstice Advanced Materials, SOLS, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Executive Compensation, Beneficial Ownership, Equity Holdings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.